ダプトマイシンの世界市場動向・分析2018-2025

【英語タイトル】Global Daptomycin Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料(QYR8D02615)・商品コード:QYR8D02615
・発行会社(調査会社):QYResearch
・発行日:2018年11月14日
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥539,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD9,800 ⇒換算¥1,078,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、ダプトマイシンの世界市場について調査・分析し、種類別には、350mg凍結乾燥パウダー、500mg凍結乾燥パウダーに、用途別には、大人、小児患者(1~17歳)に区分してまとめました。調査対象企業は、Merck & Co.、Pfizer、Teva、Mylan、Fresenius Kabi、Sagent Pharmaceuticals、Xellia、Hisun、HENGRUI PHARMA、Huadong Medicine等です。

・レポートの概要
・グローバル成長トレンド
・ダプトマイシンの世界市場規模
・ダプトマイシンの地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別ダプトマイシンの価格動向
・ダプトマイシンの種類別市場規模(350mg凍結乾燥パウダー、500mg凍結乾燥パウダー)
・ダプトマイシンの用途別市場規模(大人、小児患者(1~17歳))
・ダプトマイシンの北米市場(アメリカ、カナダ、メキシコ)
・ダプトマイシンのヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・ダプトマイシンのアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・ダプトマイシンの中南米市場(ブラジル等)
・ダプトマイシンの中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(Merck & Co.、Pfizer、Teva、Mylan、Fresenius Kabi、Sagent Pharmaceuticals、Xellia、Hisun、HENGRUI PHARMA、Huadong Medicine)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・ダプトマイシンの市場規模予測
・ダプトマイシンの種類別市場予測2018-2025(350mg凍結乾燥パウダー、500mg凍結乾燥パウダー)
・ダプトマイシンの用途別市場予測2018-2025(大人、小児患者(1~17歳))
・ダプトマイシンの北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・ダプトマイシンのヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・ダプトマイシンのアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・ダプトマイシンの中南米市場予測2018-2025(ブラジル等)
・ダプトマイシンの中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.In 2018, the global Daptomycin market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Daptomycin.

This study researches the market size of Daptomycin, presents the global Daptomycin sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Daptomycin in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Daptomycin for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Merck & Co.
Pfizer
Teva
Mylan
Fresenius Kabi
Sagent Pharmaceuticals
Xellia
Hisun
HENGRUI PHARMA
Huadong Medicine

Market Segment by Product Type
350 mg lyophilized powder
500 mg lyophilized powder

Market Segment by Application
Adult
Pediatric patients (1 to 17 years of age)

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Daptomycin status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Daptomycin manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Daptomycin are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Daptomycin Market Size Growth Rate by Type
1.3.2 350 mg lyophilized powder
1.3.3 500 mg lyophilized powder
1.4 Market Segment by Application
1.4.1 Global Daptomycin Market Share by Application (2018-2025)
1.4.2 Adult
1.4.3 Pediatric patients (1 to 17 years of age)
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Daptomycin Market Size
2.1.1 Global Daptomycin Revenue 2013-2025
2.1.2 Global Daptomycin Sales 2013-2025
2.2 Daptomycin Growth Rate by Regions
2.2.1 Global Daptomycin Sales by Regions 2013-2018
2.2.2 Global Daptomycin Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Daptomycin Sales by Manufacturers
3.1.1 Daptomycin Sales by Manufacturers 2013-2018
3.1.2 Daptomycin Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Daptomycin Revenue by Manufacturers (2013-2018)
3.2.2 Daptomycin Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Daptomycin Market Concentration Ratio (CR5 and HHI)
3.3 Daptomycin Price by Manufacturers
3.4 Key Manufacturers Daptomycin Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Daptomycin Market
3.6 Key Manufacturers Daptomycin Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 350 mg lyophilized powder Sales and Revenue (2013-2018)
4.1.2 500 mg lyophilized powder Sales and Revenue (2013-2018)
4.2 Global Daptomycin Sales Market Share by Type
4.3 Global Daptomycin Revenue Market Share by Type
4.4 Daptomycin Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Daptomycin Sales by Application

6 North America
6.1 North America Daptomycin Breakdown Data by Company
6.2 North America Daptomycin Breakdown Data by Type
6.3 North America Daptomycin Breakdown Data by Application
6.4 North America Daptomycin Breakdown Data by Countries
6.4.1 North America Daptomycin Sales by Countries
6.4.2 North America Daptomycin Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Daptomycin Breakdown Data by Company
7.2 Europe Daptomycin Breakdown Data by Type
7.3 Europe Daptomycin Breakdown Data by Application
7.4 Europe Daptomycin Breakdown Data by Countries
7.4.1 Europe Daptomycin Sales by Countries
7.4.2 Europe Daptomycin Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Daptomycin Breakdown Data by Company
8.2 Asia Pacific Daptomycin Breakdown Data by Type
8.3 Asia Pacific Daptomycin Breakdown Data by Application
8.4 Asia Pacific Daptomycin Breakdown Data by Countries
8.4.1 Asia Pacific Daptomycin Sales by Countries
8.4.2 Asia Pacific Daptomycin Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Daptomycin Breakdown Data by Company
9.2 Central & South America Daptomycin Breakdown Data by Type
9.3 Central & South America Daptomycin Breakdown Data by Application
9.4 Central & South America Daptomycin Breakdown Data by Countries
9.4.1 Central & South America Daptomycin Sales by Countries
9.4.2 Central & South America Daptomycin Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Daptomycin Breakdown Data by Type
10.2 Middle East and Africa Daptomycin Breakdown Data by Application
10.3 Middle East and Africa Daptomycin Breakdown Data by Countries
10.3.1 Middle East and Africa Daptomycin Sales by Countries
10.3.2 Middle East and Africa Daptomycin Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Daptomycin
11.1.4 Daptomycin Product Introduction
11.1.5 Merck & Co. Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Daptomycin
11.2.4 Daptomycin Product Introduction
11.2.5 Pfizer Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Daptomycin
11.3.4 Daptomycin Product Introduction
11.3.5 Teva Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Daptomycin
11.4.4 Daptomycin Product Introduction
11.4.5 Mylan Recent Development
11.5 Fresenius Kabi
11.5.1 Fresenius Kabi Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Daptomycin
11.5.4 Daptomycin Product Introduction
11.5.5 Fresenius Kabi Recent Development
11.6 Sagent Pharmaceuticals
11.6.1 Sagent Pharmaceuticals Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Daptomycin
11.6.4 Daptomycin Product Introduction
11.6.5 Sagent Pharmaceuticals Recent Development
11.7 Xellia
11.7.1 Xellia Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Daptomycin
11.7.4 Daptomycin Product Introduction
11.7.5 Xellia Recent Development
11.8 Hisun
11.8.1 Hisun Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Daptomycin
11.8.4 Daptomycin Product Introduction
11.8.5 Hisun Recent Development
11.9 HENGRUI PHARMA
11.9.1 HENGRUI PHARMA Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Daptomycin
11.9.4 Daptomycin Product Introduction
11.9.5 HENGRUI PHARMA Recent Development
11.10 Huadong Medicine
11.10.1 Huadong Medicine Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Daptomycin
11.10.4 Daptomycin Product Introduction
11.10.5 Huadong Medicine Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Daptomycin Sales Channels
12.2.2 Daptomycin Distributors
12.3 Daptomycin Customers

13 Market Forecast
13.1 Global Daptomycin Sales and Revenue Forecast 2018-2025
13.2 Global Daptomycin Sales Forecast by Type
13.3 Global Daptomycin Sales Forecast by Application
13.4 Daptomycin Forecast by Regions
13.4.1 Global Daptomycin Sales Forecast by Regions 2018-2025
13.4.2 Global Daptomycin Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Daptomycin Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Daptomycin Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Daptomycin Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Daptomycin Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Daptomycin Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Daptomycin Product Picture
Table Daptomycin Key Market Segments
Table Major Manufacturers Daptomycin Covered in This Report
Table Global Daptomycin Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Daptomycin Sales Market Shar by Type 2013-2025
Figure 350 mg lyophilized powder Figures
Table Major Manufacturers of 350 mg lyophilized powder
Figure 500 mg lyophilized powder Figures
Table Major Manufacturers of 500 mg lyophilized powder
Table Global Daptomycin Market Share by Application 2018-2025 (K Units)
Figure Adult Use Case
Figure Pediatric patients (1 to 17 years of age) Use Case
Figure Daptomycin Report Years Considered
Figure Global Daptomycin Market Size 2013-2025 (Million US$)
Figure Global Daptomycin Sales 2013-2018 (K Units)
Table Global Daptomycin Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Daptomycin Sales by Regions 2013-2018 (K Units)
Table Global Daptomycin Sales Market Share by Regions 2013-2018
Figure Global Daptomycin Sales Market Share by Regions 2013-2018
Figure Global Daptomycin Sales Market Share by Regions in 2018
Table Global Daptomycin Revenue by Regions 2013-2018 (Million US$)
Table Global Daptomycin Revenue Market Share by Regions 2013-2018
Figure Global Daptomycin Revenue Market Share by Regions 2013-2018
Figure Global Daptomycin Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Daptomycin Sales by Manufacturers (2013-2018) (K Units)
Table Global Daptomycin Sales Share by Manufacturers (2013-2018)
Figure Global Daptomycin Sales Share by Manufacturers in 2018
Table Daptomycin Revenue by Manufacturers (2013-2018) (Million USD)
Table Daptomycin Revenue Share by Manufacturers (2013-2018)
Figure Daptomycin Value Share by Manufacturers in 2018
Table Global Daptomycin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Daptomycin Price (2013-2018) (USD/Unit)
Table Key Manufacturers Daptomycin Plants/Factories Distribution
Table Key Manufacturers Daptomycin Area Served
Table Date of Key Manufacturers Enter into Daptomycin Market
Table Key Manufacturers Daptomycin Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global 350 mg lyophilized powder Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global 500 mg lyophilized powder Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Daptomycin Sales by Type (2013-2018) (K Units)
Table Global Daptomycin Sales Share by Type (2013-2018)
Figure Global Daptomycin Sales Market Share by Type (2013-2018)
Figure Global Daptomycin Sales Market Share by Type in 2017
Table Global Daptomycin Revenue by Type (2013-2018) (Million US$)
Table Global Daptomycin Revenue Share by Type (2013-2018)
Figure Global Daptomycin Revenue Market Share by Type (2013-2018)
Figure Global Daptomycin Revenue Market Share by Type in 2017
Table Daptomycin Price by Type 2013-2018 (USD/Unit)
Table Global Daptomycin Sales by Application (2013-2018) (K Units)
Table Global Daptomycin Sales Share by Application (2013-2018)
Figure Global Sales Daptomycin Market Share by Application (2013-2018)
Figure Global Sales Daptomycin Market Share by Application in 2017
Figure North America Daptomycin Sales Growth Rate 2013-2018 (K Units)
Figure North America Daptomycin Revenue Growth Rate 2013-2018 (Million US$)
Table North America Daptomycin Sales by Company (2013-2018) (K Units)
Table North America Daptomycin Sales Market Share by Company (2013-2018)
Figure North America Daptomycin Sales Market Share by Company in 2018
Table North America Daptomycin Sales by Type (2013-2018) (K Units)
Table North America Daptomycin Sales Market Share by Type (2013-2018)
Figure North America Daptomycin Market Share by Type in 2018
Table North America Daptomycin Sales by Application (2013-2018) (K Units)
Table North America Daptomycin Sales Market Share by Application (2013-2018)
Figure North America Daptomycin Market Share by Application in 2018
Table North America Daptomycin Sales by Countries (2013-2018) (K Units)
Table North America Daptomycin Sales Market Share by Countries (2013-2018)
Figure 2017 North America Daptomycin Sales Market Share by Countries
Table North America Daptomycin Revenue by Countries (2013-2018) (Million US$)
Table North America Daptomycin Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Daptomycin Revenue Market Share by Countries
Figure United States Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Canada Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Europe Daptomycin Sales Growth Rate 2013-2018 (K Units)
Figure Europe Daptomycin Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Daptomycin Sales by Company (2013-2018) (K Units)
Table Europe Daptomycin Sales Market Share by Company (2013-2018)
Figure Europe Daptomycin Sales Market Share by Company in 2018
Table Europe Daptomycin Sales by Type (2013-2018) (K Units)
Table Europe Daptomycin Sales Market Share by Type (2013-2018)
Figure 2017 Europe Daptomycin Market Share by Type
Table Europe Daptomycin Sales by Application (2013-2018) (K Units)
Table Europe Daptomycin Sales Market Share by Application (2013-2018)
Figure 2017 Europe Daptomycin Market Share by Application
Table Europe Daptomycin Sales by Countries (2013-2018) (K Units)
Table Europe Daptomycin Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Daptomycin Sales Market Share by Countries
Table Europe Daptomycin Revenue by Countries (2013-2018) (Million US$)
Table Europe Daptomycin Revenue Market Share by Countries (2013-2018)
Figure Europe Daptomycin Revenue Market Share by Countries in 2018
Figure Germany Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure France Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure UK Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Italy Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Russia Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Daptomycin Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Daptomycin Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Daptomycin Sales by Company (2013-2018) (K Units)
Table Asia Pacific Daptomycin Sales Market Share by Company (2013-2018)
Figure Asia Pacific Daptomycin Sales Market Share by Company in 2018
Table Asia Pacific Daptomycin Sales by Type (2013-2018) (K Units)
Table Asia Pacific Daptomycin Sales Market Share by Type (2013-2018)
Figure Asia Pacific Daptomycin Market Share by Type in 2018
Table Asia Pacific Daptomycin Sales by Application (2013-2018) (K Units)
Table Asia Pacific Daptomycin Sales Market Share by Application (2013-2018)
Figure Asia Pacific Daptomycin Market Share by Application in 2018
Table Asia Pacific Daptomycin Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Daptomycin Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Daptomycin Sales Market Share by Countries
Table Asia Pacific Daptomycin Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Daptomycin Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Daptomycin Revenue Market Share by Countries
Figure China Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure China Daptomycin Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Japan Daptomycin Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Korea Daptomycin Revenue Growth Rate (2013-2018) (Million US$)
Figure India Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure India Daptomycin Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Australia Daptomycin Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Daptomycin Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Daptomycin Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Daptomycin Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Daptomycin Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Daptomycin Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Daptomycin Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Daptomycin Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Daptomycin Sales by Company (2013-2018) (K Units)
Table Central & South America Daptomycin Sales Market Share by Company (2013-2018)
Figure Central & South America Daptomycin Sales Market Share by Company in 2018
Table Central & South America Daptomycin Sales by Type (2013-2018) (K Units)
Table Central & South America Daptomycin Sales Market Share by Type (2013-2018)
Figure Central & South America Daptomycin Market Share by Type in 2018
Table Central & South America Daptomycin Sales by Application (2013-2018) (K Units)
Table Central & South America Daptomycin Sales Market Share by Application (2013-2018)
Figure Central & South America Daptomycin Market Share by Application in 2018
Table Central & South America Daptomycin Sales by Countries (2013-2018) (K Units)
Table Central & South America Daptomycin Sales Market Share by Countries (2013-2018)
Figure Central & South America Daptomycin Sales Market Share by Countries in 2018
Table Central & South America Daptomycin Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Daptomycin Revenue Market Share by Countries (2013-2018)
Figure Central & South America Daptomycin Revenue Market Share by Countries in 2018
Figure Brazil Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Daptomycin Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Daptomycin Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Daptomycin Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Daptomycin Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Daptomycin Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Daptomycin Market Share by Type
Table Middle East and Africa Daptomycin Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Daptomycin Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Daptomycin Market Share by Application
Table Middle East and Africa Daptomycin Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Daptomycin Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Daptomycin Sales Market Share by Countries
Table Middle East and Africa Daptomycin Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Daptomycin Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Daptomycin Revenue Market Share by Countries
Figure GCC Countries Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Daptomycin Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Daptomycin Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Daptomycin Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Daptomycin Revenue Growth Rate (2013-2018) (K Units)
Table Merck & Co. Company Details
Table Merck & Co. Description and Business Overview
Table Merck & Co. Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merck & Co. Daptomycin Sales Growth Rate (2013-2018)
Table Merck & Co. Daptomycin Sales Market Share in Global Market
Table Merck & Co. Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Pfizer Daptomycin Sales Growth Rate (2013-2018)
Table Pfizer Daptomycin Sales Market Share in Global Market
Table Pfizer Recent Development
Table Teva Company Details
Table Teva Description and Business Overview
Table Teva Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Teva Daptomycin Sales Growth Rate (2013-2018)
Table Teva Daptomycin Sales Market Share in Global Market
Table Teva Recent Development
Table Mylan Company Details
Table Mylan Description and Business Overview
Table Mylan Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Mylan Daptomycin Sales Growth Rate (2013-2018)
Table Mylan Daptomycin Sales Market Share in Global Market
Table Mylan Recent Development
Table Fresenius Kabi Company Details
Table Fresenius Kabi Description and Business Overview
Table Fresenius Kabi Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Fresenius Kabi Daptomycin Sales Growth Rate (2013-2018)
Table Fresenius Kabi Daptomycin Sales Market Share in Global Market
Table Fresenius Kabi Recent Development
Table Sagent Pharmaceuticals Company Details
Table Sagent Pharmaceuticals Description and Business Overview
Table Sagent Pharmaceuticals Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Sagent Pharmaceuticals Daptomycin Sales Growth Rate (2013-2018)
Table Sagent Pharmaceuticals Daptomycin Sales Market Share in Global Market
Table Sagent Pharmaceuticals Recent Development
Table Xellia Company Details
Table Xellia Description and Business Overview
Table Xellia Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Xellia Daptomycin Sales Growth Rate (2013-2018)
Table Xellia Daptomycin Sales Market Share in Global Market
Table Xellia Recent Development
Table Hisun Company Details
Table Hisun Description and Business Overview
Table Hisun Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Hisun Daptomycin Sales Growth Rate (2013-2018)
Table Hisun Daptomycin Sales Market Share in Global Market
Table Hisun Recent Development
Table HENGRUI PHARMA Company Details
Table HENGRUI PHARMA Description and Business Overview
Table HENGRUI PHARMA Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table HENGRUI PHARMA Daptomycin Sales Growth Rate (2013-2018)
Table HENGRUI PHARMA Daptomycin Sales Market Share in Global Market
Table HENGRUI PHARMA Recent Development
Table Huadong Medicine Company Details
Table Huadong Medicine Description and Business Overview
Table Huadong Medicine Daptomycin Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Huadong Medicine Daptomycin Sales Growth Rate (2013-2018)
Table Huadong Medicine Daptomycin Sales Market Share in Global Market
Table Huadong Medicine Recent Development
Figure Daptomycin Value Chain
Table Daptomycin Distributors List
Table Daptomycin Customers List
Table Global Daptomycin Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Daptomycin Sales Forecast 2018-2025 (K Units)
Figure Global Daptomycin Revenue Forecast 2018-2025 (Million US$)
Table Global Daptomycin Sales Forecast by Type 2018-2025 (K Units)
Figure Global Daptomycin Sales Forecast by Type 2018-2025 (K Units)
Figure Global Daptomycin Sales Market Share Forecast by Type 2018-2025
Table Global Daptomycin Sales Forecast by Application 2018-2025 (K Units)
Figure Global Daptomycin Sales Forecast by Application 2018-2025 (K Units)
Figure Global Daptomycin Sales Market Share Forecast by Application 2018-2025
Table Global Daptomycin Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Daptomycin Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Daptomycin Sales Market Share Forecast by Regions 2018-2025
Table Global Daptomycin Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Daptomycin Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Daptomycin Revenue Market Share Forecast by Regions 2018-2025
Table North America Daptomycin Sales Forecast by Countries 2018-2025 (K Units)
Table North America Daptomycin Sales Market Share Forecast by Countries 2018-2025
Table North America Daptomycin Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Daptomycin Revenue Market Share Forecast by Countries 2018-2025
Figure United States Daptomycin Sales Forecast 2018-2025 (K Units)
Figure Canada Daptomycin Sales Forecast 2018-2025 (K Units)
Figure MexicoDaptomycin Sales Forecast 2018-2025 (K Units)
Table Europe Daptomycin Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Daptomycin Sales Market Share Forecast by Countries 2018-2025
Table Europe Daptomycin Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Daptomycin Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Daptomycin Sales Forecast 2018-2025 (K Units)
Figure France Daptomycin Sales Forecast 2018-2025 (K Units)
Figure UK Daptomycin Sales Forecast 2018-2025 (K Units)
Figure Italy Daptomycin Sales Forecast 2018-2025 (K Units)
Figure Russia Daptomycin Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Daptomycin Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Daptomycin Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Daptomycin Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Daptomycin Revenue Market Share Forecast by Countries 2018-2025
Figure China Daptomycin Sales Forecast 2018-2025 (K Units)
Figure Japan Daptomycin Sales Forecast 2018-2025 (K Units)
Figure Korea Daptomycin Sales Forecast 2018-2025 (K Units)
Figure India Daptomycin Sales Forecast 2018-2025 (K Units)
Figure Australia Daptomycin Sales Forecast 2018-2025 (K Units)
Figure Indonesia Daptomycin Sales Forecast 2018-2025 (K Units)
Figure Thailand Daptomycin Sales Forecast 2018-2025 (K Units)
Figure Malaysia Daptomycin Sales Forecast 2018-2025 (K Units)
Figure Philippines Daptomycin Sales Forecast 2018-2025 (K Units)
Figure Vietnam Daptomycin Sales Forecast 2018-2025 (K Units)
Table Central & South America Daptomycin Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Daptomycin Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Daptomycin Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Daptomycin Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Daptomycin Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Daptomycin Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Daptomycin Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Daptomycin Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Daptomycin Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Daptomycin Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Daptomycin Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Daptomycin Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Merck & Co.、Pfizer、Teva、Mylan、Fresenius Kabi、Sagent Pharmaceuticals、Xellia、Hisun、HENGRUI PHARMA、Huadong Medicine

★調査レポート[ダプトマイシンの世界市場動向・分析2018-2025] (コード:QYR8D02615)販売に関する免責事項を必ずご確認ください。
★調査レポート[ダプトマイシンの世界市場動向・分析2018-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆